Need help or have questions about your order? Call 510-991-8265Questions about your order? Call 510-991-8265

Sign InShop GLPs
Shop GLPs

Hair

Finasteride: the research history.

Finasteride appears as a 1 mg tablet and in oral and topical minoxidil combinations. The same ingredient name connects these products, while route and concentration separate their research questions.

3,455records matching the ingredient search
3connected formulations
6displayed publication records

How the research connects to the formula

The 1998 study listed below tested oral finasteride 1 mg daily in men with androgenetic alopecia. That regimen is directly relevant to understanding the tablet’s research history. It does not make a topical finasteride combination identical to the trial treatment.

The oral blend lists finasteride 1.25 mg with minoxidil 1 mg; the topical blend lists finasteride 0.1% with minoxidil 6%. Keeping these fields visible prevents a result from silently moving between formulations.

Current HealthRX.com formulation map
ProductListed formulationConnected ingredient research
Finasteride 1mg1mgFinasteride
Minoxidil 6% / Finasteride 0.1% TopicalMinoxidil 6% / Finasteride 0.1%Minoxidil · Finasteride
Minoxidil 1mg / Finasteride 1.25mgMinoxidil 1mg / Finasteride 1.25mgMinoxidil · Finasteride

Publication history

When the ingredient appeared in the literature

The chart counts records mentioning the search terms in their title or abstract. It includes research beyond hair. Use the period controls to inspect the count.

2026: 142 indexed publications. 2026 includes publications dated through October 5. The earlier bars cover longer periods than the annual bars.

View the chart as a data table
PeriodPublications
1900-19590
1960-19690
1970-19790
1980-19891
1990-1999540
2000-2009986
2010-2014495
2015-2019554
2020117
2021105
2022102
2023115
2024136
2025162
2026142
Search query and data source

Source: Europe PMC’s PubMed-indexed records. Retrieved October 5, 2026. The index’s firstPublicationDate field supplies the dates and chart periods; it can normalize a month-only record to the first day of the month. Dates through October 5 are included. Counts can change as the index adds or corrects records.

TITLE_ABS:(finasteride) AND SRC:MED AND FIRST_PDATE:[1900-01-01 TO 2026-10-05]

Open this literature search · Download the data

Dated publications

Read individual records in context

The timeline combines selected references with a sample from the ingredient search. Dates use the index’s firstPublicationDate field; the PubMed record may distinguish an earlier online date from the print date. Written study notes appear alongside the records that have them. Other entries show the indexed bibliography and link to the paper.

Clinical Trial · Multicenter Study · Randomized Controlled Trial · Journal Article

Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.

Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, Price VH, Van Neste D, Roberts JL, Hordinsky M, Shapiro J, Binkowitz B, Gormley GJ. Journal of the American Academy of Dermatology. PMID 9777765.

Study design
Two one-year randomized trials, 1,553 men; blinded extension in 1,215
What was tested
Oral finasteride 1 mg daily versus placebo in men aged 18 to 41 with male pattern hair loss.
What was reported
Hair counts and the participant, investigator and photograph assessments favored finasteride at one and two years.
How it connects to the catalog
The study concerns oral 1 mg finasteride. Its result should retain that route, dose and population when compared with oral or topical combinations.
Read the PubMed record · Publisher record

Study comparison

PublicationDesign and regimenReported findingInterpretation
1998-10-01: Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.Two one-year randomized trials, 1,553 men; blinded extension in 1,215. Oral finasteride 1 mg daily versus placebo in men aged 18 to 41 with male pattern hair loss.Hair counts and the participant, investigator and photograph assessments favored finasteride at one and two years.The study concerns oral 1 mg finasteride. Its result should retain that route, dose and population when compared with oral or topical combinations.

Questions that shape the comparison

Was finasteride tested alone or in a combination? Did the study measure hair count at a defined scalp site, visible appearance or progression over time?

Source records

Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, Price VH, Van Neste D, Roberts JL, Hordinsky M, Shapiro J, Binkowitz B, Gormley GJ.Journal of the American Academy of Dermatology. 1998-10-01. PMID 9777765. Clinical Trial, Multicenter Study, Randomized Controlled Trial, Journal Article.
Efficacy and safety of oral finasteride <i>versus</i> dutasteride in moderate-to-severe androgenetic alopecia in males based on trichoscopic and laboratory findings: a clinical comparison in Iran.Poostiyan N, Nikyar Z, Makhmali R, Hosseini M, Shahmoradi Z.The Journal of dermatological treatment. 2026-07-17. PMID 42466626. Comparative Study, Randomized Controlled Trial, Journal Article.
Incidence of type 2 diabetes mellitus in men receiving finasteride and tamsulosin: a cross-validation cohort study using data from China and UK populations.You Y, Meng X, Li Y, Chen J, Yuan Q, Liu M, Wei L, Zheng R, Wang S.Diabetes research and clinical practice. 2026-08-06. PMID 42562182. Journal Article.
No Evidence of Post-Finasteride Syndrome in 267,983 Person-Years Follow-up in the Prostate Cancer Prevention Trial.Till C, Tangen CM, Goodman P, Unger JM, Thompson IM.Urology. 2026-08-22. PMID 42628582. research-article, Journal Article.
Biosome Therapy for Androgenetic Alopecia in a Patient With Incomplete Response to Minoxidil and Finasteride: A Case Report.Almashali M.Clinical case reports. 2026-09-29. PMID 42818892. case-study, Journal Article.
Finasteride tapering allows continuation of therapy in men with male pattern hair loss who develop sexual side effects: A retrospective study.Kushnir-Grinbaum D, Dias FR, Triwongwaranat D, Yong SS, O'Reilly L, Wirapanduta D, Smith BRC, Sinclair R, Bhoyrul B.Journal of the American Academy of Dermatology. 2026-10-01. PMID 42822773. Journal Article.

Research data assembled by HealthRX.com from the displayed source records, October 5, 2026. The atlas contains a dated literature search and selected studies; it is not an exhaustive systematic review.